SE0003476D0 - Compounds - Google Patents

Compounds

Info

Publication number
SE0003476D0
SE0003476D0 SE0003476A SE0003476A SE0003476D0 SE 0003476 D0 SE0003476 D0 SE 0003476D0 SE 0003476 A SE0003476 A SE 0003476A SE 0003476 A SE0003476 A SE 0003476A SE 0003476 D0 SE0003476 D0 SE 0003476D0
Authority
SE
Sweden
Prior art keywords
sup
compounds
diseases
general formula
pharmaceutical composition
Prior art date
Application number
SE0003476A
Other languages
English (en)
Swedish (sv)
Inventor
Peter Bernstein
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0003476A priority Critical patent/SE0003476D0/xx
Publication of SE0003476D0 publication Critical patent/SE0003476D0/xx
Priority to JP2002531108A priority patent/JP2004509954A/ja
Priority to ES01970480T priority patent/ES2288988T3/es
Priority to US10/381,755 priority patent/US6924277B2/en
Priority to AU2001290480A priority patent/AU2001290480A1/en
Priority to PCT/SE2001/002100 priority patent/WO2002026724A1/en
Priority to EP01970480A priority patent/EP1324992B1/en
Priority to AT01970480T priority patent/ATE369348T1/de
Priority to DE60129829T priority patent/DE60129829T2/de
Priority to US11/115,572 priority patent/US20050192318A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/22—Eight-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE0003476A 2000-09-28 2000-09-28 Compounds SE0003476D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0003476A SE0003476D0 (sv) 2000-09-28 2000-09-28 Compounds
JP2002531108A JP2004509954A (ja) 2000-09-28 2001-09-27 治療に用いるための環化したベンズアミドニューロキニンアンタゴニスト
ES01970480T ES2288988T3 (es) 2000-09-28 2001-09-27 Antagonistas de benzamida-neurokinina ciclados para su uso en terapia.
US10/381,755 US6924277B2 (en) 2000-09-28 2001-09-27 Cyclized benzamide neurokinin antagonists for use in therapy
AU2001290480A AU2001290480A1 (en) 2000-09-28 2001-09-27 Cyclized benzamide neurokinin antagonists for use in therapy
PCT/SE2001/002100 WO2002026724A1 (en) 2000-09-28 2001-09-27 Cyclized benzamide neurokinin antagonists for use in therapy
EP01970480A EP1324992B1 (en) 2000-09-28 2001-09-27 Cyclized benzamide neurokinin antagonists for use in therapy
AT01970480T ATE369348T1 (de) 2000-09-28 2001-09-27 Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
DE60129829T DE60129829T2 (de) 2000-09-28 2001-09-27 Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in der therapie
US11/115,572 US20050192318A1 (en) 2000-09-28 2005-04-27 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0003476A SE0003476D0 (sv) 2000-09-28 2000-09-28 Compounds

Publications (1)

Publication Number Publication Date
SE0003476D0 true SE0003476D0 (sv) 2000-09-28

Family

ID=20281199

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0003476A SE0003476D0 (sv) 2000-09-28 2000-09-28 Compounds

Country Status (9)

Country Link
US (2) US6924277B2 (enExample)
EP (1) EP1324992B1 (enExample)
JP (1) JP2004509954A (enExample)
AT (1) ATE369348T1 (enExample)
AU (1) AU2001290480A1 (enExample)
DE (1) DE60129829T2 (enExample)
ES (1) ES2288988T3 (enExample)
SE (1) SE0003476D0 (enExample)
WO (1) WO2002026724A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013205A1 (en) * 2004-08-04 2006-02-09 Solvay Pharmaceuticals B.V. Neurokinin-1 receptor antagonists for the treatment of conditions responsive to testosterone elevation
US20060030556A1 (en) * 2004-08-04 2006-02-09 Solvay Pharmaceuticals B.V. Neurokinin-1 receptor antagonists for the treatment of conditions responsive to testosterone elevation, including testosterone deficiency
DE102004038134B4 (de) 2004-08-05 2013-07-25 Johann Wolfgang Goethe-Universität Frankfurt am Main Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
US20060030600A1 (en) * 2004-08-06 2006-02-09 Patrick Schnider Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia
EP1976495A2 (en) * 2006-01-06 2008-10-08 Aarhus Universitet Compounds acting on the serotonin transporter
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
WO2012061754A2 (en) * 2010-11-05 2012-05-10 The Broad Institute, Inc. Compounds and methods for treating autoimmune diseases
EP2691391A4 (en) 2011-03-29 2014-09-10 Broad Inst Inc COMPOUNDS AND METHODS OF TREATING DISORDERS MEDIATED BY ISOCITRATE DEHYDROGENASE
ES2672099T3 (es) 2011-07-04 2018-06-12 Irbm - Science Park S.P.A. Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
TW201427947A (zh) 2012-10-12 2014-07-16 Lundbeck & Co As H 環狀胺
TWI598325B (zh) * 2012-10-12 2017-09-11 Ｈ 朗德貝克公司 苯甲醯胺類
ES2980110T3 (es) 2018-02-26 2024-09-30 Ospedale San Raffaele Srl Antagonistas de NK-1 para uso en el tratamiento del dolor ocular
RU2697414C1 (ru) 2018-05-11 2019-08-14 Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" Новый антагонист тахикининовых рецепторов и его применение
PE20211644A1 (es) 2018-09-18 2021-08-24 Terns Inc Compuestos para tratar ciertas leucemias
EP4117673A1 (en) 2020-03-11 2023-01-18 Ospedale San Raffaele S.r.l. Treatment of stem cell deficiency
WO2023051681A1 (zh) * 2021-09-30 2023-04-06 江苏豪森药业集团有限公司 四元稠环类化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2935541B2 (ja) * 1990-06-28 1999-08-16 サントリー株式会社 縮合複素環化合物
US5525600A (en) 1994-11-28 1996-06-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
GB9505084D0 (en) * 1995-03-14 1995-05-03 Pfizer Ltd Benzamide derivative
US5541179A (en) 1995-05-02 1996-07-30 American Home Products Corporation Tropon-2-one piperazine carboxamides as serotonergic agents
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5789422A (en) 1996-10-28 1998-08-04 Schering Corporation Substituted arylalkylamines as neurokinin antagonists
GB9922521D0 (en) * 1998-10-07 1999-11-24 Zeneca Ltd Compounds
FR2792835B3 (fr) 1999-04-27 2001-05-25 Sanofi Sa Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression
DE60134735D1 (de) * 2000-04-06 2008-08-21 Astrazeneca Ab Neue neurokinin-antagonisten zum gebrauch als arzneimittel

Also Published As

Publication number Publication date
WO2002026724A1 (en) 2002-04-04
DE60129829D1 (de) 2007-09-20
AU2001290480A1 (en) 2002-04-08
US6924277B2 (en) 2005-08-02
EP1324992A1 (en) 2003-07-09
US20050192318A1 (en) 2005-09-01
ATE369348T1 (de) 2007-08-15
ES2288988T3 (es) 2008-02-01
DE60129829T2 (de) 2008-04-30
JP2004509954A (ja) 2004-04-02
US20040029850A1 (en) 2004-02-12
EP1324992B1 (en) 2007-08-08

Similar Documents

Publication Publication Date Title
IS6658A (is) Ný efnasambönd
IS6520A (is) Ný efnasambönd
DK1200418T3 (da) Nematodicide trifluorbutener
ATE316083T1 (de) Adamantanderivate
SE0302139D0 (sv) Novel compounds
ATE386725T1 (de) Heterocyclylverbindungen
SE0003476D0 (sv) Compounds
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
NO20020282L (no) Nytt difenyl-piperidinderivat
AU1182702A (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
SE0101038D0 (sv) Novel compounds
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
DK1532131T3 (da) Motilid-forbindelser
SE0303280D0 (sv) Novel compounds
SE9903290D0 (sv) Novel compounds
UY27587A1 (es) Heterociclos terapéuticos
PT1204659E (pt) Benzofuranos serotoninergicos
ID25478A (id) Agonis 5-ht1f
SE0302755D0 (sv) Novel compounds
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
SE0004827D0 (sv) Therapeutic compounds
ATE293591T1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
DE50211461D1 (de) Pharmazeutische zusammensetzung enthaltend bulbophyllum